HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Elizabeth A Stewart Selected Research

Anemia

10/2023Relugolix combination therapy in Black/African American women with symptomatic uterine fibroids: LIBERTY Long-Term Extension study.
1/2023Quality of life with relugolix combination therapy for uterine fibroids: LIBERTY randomized trials.
1/2023A plain language summary of the long-term relugolix combination therapy study for uterine fibroids.
1/2023Oral Gonadotropin-Releasing Hormone Antagonists for the Treatment of Uterine Leiomyomas.
1/2023Long-term health-related quality of life and symptom severity following hysterectomy, myomectomy, or uterine artery embolization for the treatment of symptomatic uterine fibroids.
12/2022Long-term Relugolix Combination Therapy for Symptomatic Uterine Leiomyomas.
1/2021Treatment of Uterine Fibroid Symptoms with Relugolix Combination Therapy.
1/2016Association Between Patient Characteristics and Treatment Procedure Among Patients With Uterine Leiomyomas.
1/2014Submucosal fibroids and the relation to heavy menstrual bleeding and anemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Elizabeth A Stewart Research Topics

Disease

71Leiomyoma (Uterine Fibroids)
10/2023 - 03/2002
16Menorrhagia
10/2023 - 01/2017
14Pain (Aches)
08/2023 - 06/2003
13Neoplasms (Cancer)
03/2024 - 06/2005
11Hemorrhage
04/2023 - 06/2010
11Adenomyosis
01/2023 - 03/2002
9Anemia
10/2023 - 01/2014
7Amenorrhea
10/2023 - 01/2019
7Infertility (Sterility)
10/2022 - 07/2011
4Cardiovascular Diseases (Cardiovascular Disease)
01/2023 - 03/2012
3Coronary Artery Disease (Coronary Atherosclerosis)
10/2023 - 11/2016
3Endometriosis
10/2022 - 06/2003
3Sarcoma (Soft Tissue Sarcoma)
11/2021 - 10/2018
3Pelvic Pain
05/2020 - 03/2002
3Chronic Disease (Chronic Diseases)
11/2017 - 11/2016
2Dysmenorrhea (Menstrual Pain)
01/2022 - 10/2019
2Myoma
01/2021 - 08/2007
2Rhabdoid Tumor (Rhabdoid Tumors)
01/2020 - 01/2019
2Hyperlipidemias (Hyperlipidemia)
01/2018 - 11/2016
2Cardiac Arrhythmias (Arrythmia)
01/2018 - 11/2016
2Obesity
01/2018 - 02/2016
2Necrosis
08/2007 - 03/2003
1Premature Menopause
04/2023
1Nausea
09/2021
1Neuroblastoma
03/2021
1Spontaneous Abortion (Miscarriage)
01/2021
1Carpal Tunnel Syndrome
01/2021
1Metrorrhagia (Spotting)
01/2020
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2020
1Somatoform Disorders (Somatoform Disorder)
12/2019
1Anxiety Disorders (Anxiety Disorder)
12/2019
1Mood Disorders (Mood Disorder)
12/2019
1Breast Neoplasms (Breast Cancer)
10/2019
1Lung Neoplasms (Lung Cancer)
01/2019
1Frailty
11/2018
1Fibrocystic Breast Disease (Chronic Cystic Mastitis)
11/2018
1Hypertension (High Blood Pressure)
01/2018
1Heart Failure
01/2018
1Multiple Chronic Conditions
11/2017
1Hereditary leiomyomatosis and renal cell cancer
07/2017
1Substance-Related Disorders (Drug Abuse)
01/2017

Drug/Important Bio-Agent (IBA)

8Estradiol (Delestrogen)FDA LinkGeneric
10/2023 - 01/2020
8relugolixIBA
10/2023 - 01/2021
7Norethindrone Acetate (Norlutate)FDA LinkGeneric
10/2023 - 01/2020
7elagolixIBA
01/2023 - 01/2017
5Proteins (Proteins, Gene)FDA Link
01/2023 - 03/2002
4Gonadotropin-Releasing Hormone (GnRH)FDA Link
08/2023 - 01/2020
4Hormones (Hormone)IBA
01/2023 - 06/2005
4Biomarkers (Surrogate Marker)IBA
11/2021 - 01/2018
3Hemoglobins (Hemoglobin)IBA
10/2023 - 01/2014
3Bromocriptine (Parlodel)FDA LinkGeneric
01/2023 - 10/2019
3LHRH Receptors (Gonadotropin-Releasing Hormone Receptor)IBA
01/2022 - 11/2018
3Fumarate Hydratase (Fumarase)IBA
07/2017 - 11/2004
2RNA (Ribonucleic Acid)IBA
01/2023 - 03/2021
2SteroidsIBA
01/2023 - 01/2022
2ProlactinIBA
01/2023 - 10/2019
2GadoliniumIBA
01/2018 - 08/2007
1UbiquitinIBA
03/2024
1ChromatinIBA
03/2024
1Factor V (Coagulation Factor V)IBA
03/2024
1Norethindrone (Norethisterone)FDA LinkGeneric
01/2023
1Messenger RNA (mRNA)IBA
01/2023
1MicroRNAs (MicroRNA)IBA
01/2023
1MineralsIBA
01/2023
1Clomiphene (Clomifene)FDA LinkGeneric
01/2022
1Complex MixturesIBA
01/2022
1linzagolixIBA
01/2022
1Topoisomerase I InhibitorsIBA
11/2021
1Poly(ADP-ribose) Polymerase InhibitorsIBA
11/2021
1Irinotecan (Camptosar)FDA LinkGeneric
11/2021
1talazoparibIBA
11/2021
1DNA (Deoxyribonucleic Acid)IBA
11/2021
1CytokinesIBA
03/2021
1Hemin (Panhematin)FDA Link
01/2021
1Anti-Mullerian HormoneIBA
01/2021
1Aromatase InhibitorsIBA
05/2020
1HomoharringtonineIBA
01/2020
1Gonadal Steroid Hormones (Sex Hormones)IBA
01/2020
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2019
1Oral ContraceptivesIBA
11/2018
1Progestins (Progestagens)IBA
01/2018

Therapy/Procedure

34Hysterectomy
10/2023 - 01/2002
30Therapeutics
10/2023 - 06/2003
19Ultrasonic Surgical Procedures
01/2022 - 03/2003
17Uterine Myomectomy
10/2023 - 03/2002
13Ovariectomy (Oophorectomy)
04/2023 - 01/2012
12Uterine Artery Embolization
01/2023 - 09/2011
4Drug Therapy (Chemotherapy)
11/2021 - 01/2019
2Conservative Treatment
08/2023 - 01/2010
2Endometrial Ablation Techniques
01/2018 - 01/2016
2Gynecologic Surgical Procedures (Gynecologic Surgery)
01/2012 - 06/2003
1Tubal Sterilization (Tubal Ligation)
01/2023
1Operative Surgical Procedures
01/2023
1Blood Transfusion (Blood Transfusions)
01/2023
1Barrier Contraception
01/2022
1Morcellation
01/2019
1Precision Medicine
10/2018
1Secondary Prevention
10/2018
1Intrauterine Devices (Intrauterine Device)
01/2018
1Ambulatory Care (Outpatient Care)
11/2017